BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Dexmedetomidine

An imidazole derivative that is an agonist of ADRENERGIC ALPHA-2 RECEPTORS. It is closely related to MEDETOMIDINE, which is the racemic form of this compound.

299+ PubMed studies analyzed · 40 RCTs · Evidence Score: 54.2

Research Domains

Dexmedetomidine has been studied across 18 research domains including 😴 Sleep, 💊 Pain, ❤️ Cardiovascular, 🫁 Respiratory, 🔬 Inflammation. The primary research focus is 😴 Sleep with 44% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dexmedetomidine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Clonidine
14 shared targets
Oxymetazoline
13 shared targets
Phentolamine
13 shared targets
Guanfacine
10 shared targets
Dihydroergotamine
15 shared targets
Trazodone
12 shared targets
Pergolide
13 shared targets
Guanabenz
13 shared targets
Yohimbine
12 shared targets
brimonidine
6 shared targets
Loading evidence profile...

This evidence profile for Dexmedetomidine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.